"In just the last decade, we have witnessed or even personally participated in the birth of the first gene therapy, the first cell therapy, the first gene-editing-based drug, the first small interfering RNA (siRNA) drug, the first mRNA vaccine, and this is an era in which the impossible becomes possible. It is in this context that the ecological environment of the biomedical industry in the Greater Bay Area has shown its unique charm and vitality. Dr. Hui Aimin, Executive Chairman of BIOCHINA South China Conference, Chairman and CEO of Hui Zhengqi Pharmaceutical, and Industry Professor of the State Key Laboratory of Respiratory Diseases of Guangzhou Medical University, said at the opening ceremony of the conference.
BIOCHINA 2024 SOUTH CHINA WAS SUCCESSFULLY HELD ON OCTOBER 10-11, 2024 AT NANFENG INTERNATIONAL CONVENTION AND EXHIBITION CENTER IN GUANGZHOU! The conference set up eight forums, 3,295 participants, invited 118 speakers, jointly created 84 reports, and reached more than 1,316 one-on-one appointments. A total of 103 exhibitors will be invited to link South China and focus on the Greater Bay Area, focusing on the focus and hot spots of South China's biological industry, and jointly discussing the current situation and development trend of South China's biological industry.
The exhibition gathered 103 high-quality suppliers from all over the country to participate in the exhibition, linking the upstream and downstream of the industry through product display, procurement activities and other forms, gathering the procurement department of South China biological enterprises, more efficient and convenient product exchanges, and jointly building a biological industry supply chain.
The conference forum covers antibodies, ADCs, nucleic acid drugs, cell therapy, gene therapy and other tracks, from R&D, clinical to process production, and then to commercialization, and invites 118 guests from leading companies to build high-quality forum content, including antibody drug innovation and development forum, cell therapy innovation and development forum, CBIITA policy and regulation forum, gene therapy innovation and development forum, BioBD forum, clinical development strategy forum, scientific research transformation forum, ADC industry summit, small nucleic acid drug industry summit, Cell & Gene Therapy Industry Summit.
During the conference, a total of more than 1,316 one-on-one appointments were reached, gathering Biotech founders, Pharma BD, and meeting target customers to improve the efficiency of the conference, and the senior management of investment institutions, upstream suppliers and service providers will help everyone expand network resources and cooperation opportunities in the conference through 1V1+30min negotiation opportunities.
On the opening night of October 10, the organizer held a special dinner for the Greater Bay Area Night, where everyone toasted and chatted, sang and played games, and talked and laughed about the new development of biomedicine in the Greater Bay Area!
So far, 2024 BIOCHINA South China has come to a successful conclusion! This exhibition focuses on the focus of South China's biological industry, focuses on the development of the Greater Bay Area, brings together a number of universities, research institutes and laboratories in Guangdong, Hong Kong and Macao, deeply analyzes the current situation and future development trend of South China's biological industry, discusses cutting-edge technologies and scientific research transformation with the industry, and works together to promote the high-quality development of South China's biological industry.
We have deeply felt the vigorous vitality of the bio-industry in the Greater Bay Area, and have demonstrated strong comprehensive strength and promising development potential. I believe that a lot of cooperation has been condensed at BIOCHINA South China!
I also look forward to seeing you at the Suzhou BIOCHINA2025 (10th) E-Trade Biological Industry Exhibition on March 13-15, 2025!
